Royal DSM, a global purpose-led science-based company, has repurchased 40,085 of its own shares in the period from 2 May 2022 up to and including 6 May 2022 at an average price of €156.08. This is in accordance with the repurchase program announced on 10 March 2022, covering the commitments for the final stock dividend 2021 and share based compensation plans. The consideration of this repurchase was €6.3 million.
This repurchase concludes the program to repurchase 1,330,000 shares for a total consideration of €210.1 million.
For more detailed information see 'Daily transaction details Share Repurchase Program announced 10 March 2022'.
Senior Director External Communications
+31 45 578 2420
Vice-President Investor Relations
+31 45 578 2864